HSBC Holdings’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
HSBC Holdings's IRMD Position: Q2 2026 in Review
HSBC Holdings reduced its iRadimed (IRMD) stake by 22% in Q2 2026, selling an estimated $306K and leaving 11,993 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.
HSBC Holdings first reported a position in IRMD in Q2 2020 and has held it in 15 quarters since. The position peaked at $2.1M in Q4 2025. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- HSBC Holdings held 11,993 shares of iRadimed worth $1.13M as of Q2 2026.
- HSBC Holdings sold 3,364 iRadimed shares in Q2 2026, an estimated $306K.
- iRadimed made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1879 holding.
- HSBC Holdings first reported a position in iRadimed in Q2 2020 and has held it in 15 quarters since.
- HSBC Holdings's iRadimed position peaked at $2.1M in Q4 2025.
- 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.